Spencer E. Brightman

585 total citations
14 papers, 385 citations indexed

About

Spencer E. Brightman is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Spencer E. Brightman has authored 14 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 7 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Spencer E. Brightman's work include Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and CAR-T cell therapy research (6 papers). Spencer E. Brightman is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and CAR-T cell therapy research (6 papers). Spencer E. Brightman collaborates with scholars based in United States, Italy and Netherlands. Spencer E. Brightman's co-authors include Bruce R. Zetter, Stephen P. Schoenberger, Ofer Levy, David J. Dowling, Martin S. Naradikian, Aaron M. Miller, Carlo Pietrasanta, Ilana Bergelson, Simon D. van Haren and Cristiana Guiducci and has published in prestigious journals such as Journal of Clinical Investigation, Nature Immunology and The Journal of Immunology.

In The Last Decade

Spencer E. Brightman

14 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Spencer E. Brightman United States	10	240	122	94	67	51	14	385
Lisa D. MacDonald Canada	10	172 0.7×	102 0.8×	96 1.0×	80 1.2×	40 0.8×	25	327
Matthew P. Mulè United States	10	259 1.1×	196 1.6×	105 1.1×	79 1.2×	60 1.2×	14	521
Béatris Mastelic-Gavillet Switzerland	11	358 1.5×	133 1.1×	133 1.4×	81 1.2×	42 0.8×	15	518
Deepa Mohanan Switzerland	9	296 1.2×	156 1.3×	48 0.5×	54 0.8×	85 1.7×	11	490
Genevieve Weir Canada	14	322 1.3×	175 1.4×	183 1.9×	99 1.5×	54 1.1×	37	529
Deeksha Deep United States	7	464 1.9×	204 1.7×	138 1.5×	40 0.6×	39 0.8×	9	713
Carine M. Gonçalves Portugal	11	162 0.7×	90 0.7×	61 0.6×	32 0.5×	26 0.5×	12	362
Sören Reinke United Kingdom	7	248 1.0×	188 1.5×	101 1.1×	50 0.7×	46 0.9×	11	443
Gijs G. Zom Netherlands	14	408 1.7×	215 1.8×	151 1.6×	83 1.2×	32 0.6×	17	518
Muhammad S. Ahmed United Kingdom	11	238 1.0×	148 1.2×	208 2.2×	164 2.4×	62 1.2×	19	577

Countries citing papers authored by Spencer E. Brightman

Since Specialization

Citations

This map shows the geographic impact of Spencer E. Brightman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spencer E. Brightman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spencer E. Brightman more than expected).

Fields of papers citing papers by Spencer E. Brightman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spencer E. Brightman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spencer E. Brightman. The network helps show where Spencer E. Brightman may publish in the future.

Co-authorship network of co-authors of Spencer E. Brightman

This figure shows the co-authorship network connecting the top 25 collaborators of Spencer E. Brightman. A scholar is included among the top collaborators of Spencer E. Brightman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spencer E. Brightman. Spencer E. Brightman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Brightman, Spencer E., Martin S. Naradikian, Pandurangan Vijayanand, et al.. (2025). The spontaneous neoantigen-specific CD4 ⁺ T-cell response to a growing tumor is functionally and phenotypically diverse. Journal for ImmunoTherapy of Cancer. 13(9). e012209–e012209. 1 indexed citations

Koşaloğlu, Zeynep, Angela Frentzen, Ashmitaa Logandha Ramamoorthy Premlal, et al.. (2024). A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer. Science Translational Medicine. 16(736). eabj9905–eabj9905. 6 indexed citations

Dolina, Joseph S., Spencer E. Brightman, Sara McArdle, et al.. (2023). Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression. Journal of Clinical Investigation. 133(17). 31 indexed citations

Brightman, Spencer E., Martin S. Naradikian, Ashmitaa Logandha Ramamoorthy Premlal, et al.. (2023). Neoantigen-specific stem cell memory-like CD4+ T cells mediate CD8+ T cell-dependent immunotherapy of MHC class II-negative solid tumors. Nature Immunology. 24(8). 1345–1357. 38 indexed citations

Brightman, Spencer E., Martin S. Naradikian, Ashmitaa Logandha Ramamoorthy Premlal, et al.. (2022). Tumor cells fail to present MHC-II–restricted epitopes derived from oncogenes to CD4+ T cells. JCI Insight. 8(2). 8 indexed citations

Dowling, David J., Soumik Barman, Alyson Smith, et al.. (2022). Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination. Scientific Reports. 12(1). 16860–16860. 16 indexed citations

Brightman, Spencer E., Martin S. Naradikian, Aaron M. Miller, & Stephen P. Schoenberger. (2020). Harnessing neoantigen specific CD4 T cells for cancer immunotherapy. Journal of Leukocyte Biology. 107(4). 625–633. 42 indexed citations

Queenan, Anne Marie, David J. Dowling, Kellen C. Faé, et al.. (2018). Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro. Vaccine. 37(1). 80–89. 14 indexed citations

Dowling, David J., Alyson Smith, Francesco Borriello, et al.. (2018). Age-specific TLR7/8 adjuvant formulation overcomes hyporesponsiveness to neonatal acellular pertussis vaccination in a mouse model. The Journal of Immunology. 200(Supplement_1). 180.24–180.24. 1 indexed citations

10.

Dowling, David J., Evan A. Scott, Annette Scheid, et al.. (2017). Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses. Journal of Allergy and Clinical Immunology. 140(5). 1339–1350. 108 indexed citations

11.

Borriello, Francesco, Carlo Pietrasanta, Jacqueline C.Y. Lai, et al.. (2017). Identification and Characterization of Stimulator of Interferon Genes As a Robust Adjuvant Target for Early Life Immunization. Frontiers in Immunology. 8. 1772–1772. 32 indexed citations

12.

Dowling, David J., Holly Sanders, Spencer E. Brightman, et al.. (2016). A Meningococcal Outer Membrane Vesicle Vaccine Incorporating Genetically Attenuated Endotoxin Dissociates Inflammation from Immunogenicity. Frontiers in Immunology. 7. 562–562. 23 indexed citations

13.

Oh, Djin‐Ye, David J. Dowling, Saima Ahmed, et al.. (2016). Adjuvant-induced Human Monocyte Secretome Profiles Reveal Adjuvant- and Age-specific Protein Signatures. Molecular & Cellular Proteomics. 15(6). 1877–1894. 28 indexed citations

14.

Zetter, Bruce R. & Spencer E. Brightman. (1990). Cell motility and the extracellular matrix. Current Opinion in Cell Biology. 2(5). 850–856. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact